Innate Pharma S.A. (EPA: IPH)
France
· Delayed Price · Currency is EUR 2.090
-0.020 (-0.95%)
Aug 30, 2024, 5:35 PM CET
Innate Pharma Ratios and Metrics
Market cap in millions EUR. Fiscal year is September - August.
Millions EUR. Fiscal year is Sep - Aug.
Fiscal Year | Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Aug '24 Aug 30, 2024 | Aug '23 Aug 31, 2023 | Aug '22 Aug 31, 2022 | Aug '21 Aug 31, 2021 | Aug '20 Aug 31, 2020 | Aug '19 Aug 31, 2019 | 2018 - 2014 |
| Market Capitalization | 169 | 195 | 168 | 195 | 111 | 163 | Upgrade
|
| Market Cap Growth | -5.85% | 16.18% | -13.72% | 75.15% | -31.56% | -30.53% | Upgrade
|
| Enterprise Value | 117 | 77 | 73 | 153 | 105 | 167 | Upgrade
|
| Last Close Price | 2.09 | 116.29 | 98.26 | 110.91 | 62.35 | 87.91 | Upgrade
|
| PE Ratio | - | 16.95 | 10.29 | 15.94 | 14.60 | 13.26 | Upgrade
|
| PS Ratio | 2.73 | 0.70 | 0.76 | 0.96 | 0.64 | 0.78 | Upgrade
|
| PB Ratio | 3.26 | 2.34 | 2.35 | 3.11 | 2.05 | 3.10 | Upgrade
|
| P/FCF Ratio | 50.10 | 10.23 | 3.63 | 3.81 | 8.53 | 10.71 | Upgrade
|
| P/OCF Ratio | 15.44 | 6.81 | 3.08 | 3.16 | 4.07 | 5.73 | Upgrade
|
| EV/Sales Ratio | 1.89 | 0.28 | 0.33 | 0.75 | 0.60 | 0.80 | Upgrade
|
| EV/EBITDA Ratio | 1.29 | 1.85 | 2.07 | 4.80 | 5.05 | 5.59 | Upgrade
|
| EV/EBIT Ratio | 1.69 | 2.30 | 2.82 | 6.54 | 8.50 | 8.06 | Upgrade
|
| EV/FCF Ratio | -3.54 | 4.05 | 1.58 | 2.99 | 8.05 | 11.01 | Upgrade
|
| Debt / Equity Ratio | 0.34 | 0.32 | 0.42 | 0.55 | 0.78 | 0.80 | Upgrade
|
| Debt / EBITDA Ratio | 0.50 | 0.64 | 0.84 | 1.09 | 2.04 | 1.40 | Upgrade
|
| Debt / FCF Ratio | 8.14 | 1.39 | 0.64 | 0.68 | 3.25 | 2.75 | Upgrade
|
| Asset Turnover | 1.09 | 0.98 | 0.91 | 1.03 | 0.97 | 1.21 | Upgrade
|
| Inventory Turnover | 2.71 | 3.40 | 3.73 | 4.29 | 3.40 | 4.22 | Upgrade
|
| Quick Ratio | 0.79 | 0.83 | 0.94 | 0.79 | 0.96 | 0.74 | Upgrade
|
| Current Ratio | 1.26 | 1.19 | 1.21 | 1.00 | 1.32 | 1.16 | Upgrade
|
| Return on Equity (ROE) | 20.83% | 14.35% | 23.59% | 18.66% | 13.98% | 22.27% | Upgrade
|
| Return on Assets (ROA) | 9.90% | 7.43% | 6.63% | 7.38% | 4.29% | 7.50% | Upgrade
|
| Return on Capital (ROIC) | 26.31% | 19.87% | 16.28% | 15.09% | 8.09% | 14.30% | Upgrade
|
| Earnings Yield | -4.50% | 5.85% | 9.46% | 5.95% | 6.39% | 6.79% | Upgrade
|
| FCF Yield | -19.45% | 9.78% | 27.55% | 26.28% | 11.72% | 9.34% | Upgrade
|
| Dividend Yield | 1.89% | 1.89% | 2.07% | 1.67% | 2.69% | 1.91% | Upgrade
|
| Payout Ratio | 21.10% | 29.19% | 19.18% | 23.35% | 39.34% | 21.28% | Upgrade
|
| Buyback Yield / Dilution | -0.08% | -0.00% | 0.09% | -0.03% | -0.07% | -0.01% | Upgrade
|
| Total Shareholder Return | -0.08% | 1.89% | 2.15% | 1.64% | 2.63% | 1.90% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.